Search results
Results from the WOW.Com Content Network
Da Costa's syndrome is named for the surgeon Jacob Mendes Da Costa, [16] who first observed it in soldiers during the American Civil War. At the time it was proposed, Da Costa's syndrome was seen as a very desirable [17] physiological explanation for "soldier's heart". Use of the term "Da Costa's syndrome" peaked in the early 20th century.
Jacob Mendes Da Costa, or Jacob Mendez Da Costa (February 7, 1833, Saint Thomas, Danish Virgin Islands, Caribbean – September 12, 1900) was an American physician.. He is particularly known for discovering Da Costa's syndrome (also known as soldier's heart), an anxiety disorder combining effort fatigue, dyspnea, a sighing respiration, palpitation and sweating that he first observed in ...
Idiopathic multicentric Castleman disease (iMCD) is a subtype of Castleman disease (also known as giant lymph node hyperplasia, lymphoid hamartoma, or angiofollicular lymph node hyperplasia), a group of lymphoproliferative disorders characterized by lymph node enlargement, characteristic features on microscopic analysis of enlarged lymph node tissue, and a range of symptoms and clinical findings.
In 2018, the first treatment guidelines for iMCD were established. [19] In 2020 the first evidence based diagnostic criteria and treatment guidelines were established for unicentric Castleman disease. World Castleman Disease Day was established in 2018 and is held every year on July 23.
This genetic disorder article is a stub. You can help Wikipedia by expanding it.
Treatment with steroids and thyroid hormones, [51] such as hydrocortisone, fludrocortisone, and nasal flunisolide, [52] has been studied. The evidence for corticosteroids is limited. A 2006 systematic review examined RCTs of steroids, primarily hydrocortisone, which found one with a significant difference between groups for fatigue, but two ...
Asplenia with cardiovascular anomalies, also known as Ivemark syndrome and right atrial isomerism, [1] is an example of a heterotaxy syndrome. These uncommon congenital disorders are characterized by defects in the heart, spleen and paired organs such as the lungs and kidneys. Another name is "asplenia-cardiovascular defect-heterotaxy". [2]
An eponymous disease is a disease, disorder, condition, or syndrome named after a person, usually the physician or other health care professional who first identified the disease; less commonly, a patient who had the disease; rarely, a literary character who exhibited signs of the disease or an actor or subject of an allusion, as characteristics associated with them were suggestive of symptoms ...